alexa Multidrug Resistance for Cancer Treatment: Delivery of Ursolic Acid and Caffeine by Poly (Lactic-Co-Glycolic Acid) Nanoparticles | OMICS International | Abstract

Research Article

Multidrug Resistance for Cancer Treatment: Delivery of Ursolic Acid and Caffeine by Poly (Lactic-Co-Glycolic Acid) Nanoparticles

Jose Merlin JP1*, Venkadesh B2, Sheeja S Rajan3 and Subramanian P4

1PG & Research Department of Zoology, Muslim Arts College, Thiruvithancode, Tamilnadu, India

2PG& Research Department of Zoology, Govt Arts and science college, Nandanam, Tamilnadu, India

3Department of Biochemistry, Theivanai Ammal College for Women Villupuram, Tamilnadu, India

4Department of Biochemistry and Biotechnolgy, Annamalai University, Annamalainagar, Tamilnadu, India

*Corresponding Author:
Jose Merlin JP
PG and Research Department of Zoology
Muslim arts college, Tamilnadu, India
Tel: +91 9442094520
E-mail: [email protected]

Received date: April 13, 2017; Accepted date: April 21, 2017; Published date: April 30, 2017

Citation: Merlin JJP, Venkadesh B, Rajan SS, Subramanian P (2017) Multidrug Resistance for Cancer Treatment: Delivery of Ursolic Acid and Caffeine by Poly (Lactic-Co-Glycolic Acid) Nanoparticles. J Gastrointest Cancer Stromal Tumor 2:113 doi: 10.4172/2572-4126.1000113

Copyright: © 2017 Merlin JJP, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Abstract

Multidrug-resistant (MDR) cancer may be treated using combinations of encapsulated cytotoxic drugs or chemo sensitizers. To optimize for the effectiveness of this combinational approach poly (lactic-o-glycolic acid) nanoparticle formulations capable of delivering a cytotoxic drug or chemo sensitizers, ursolic acid (UA) and Caffeine (Caf) combination were prepared. The system can be used for targeting, controlled drug delivery and also imaging of cancer cells. The prepared nanoparticles were characterized using DLS, TEM, XRD and FT-IR a studies. The drug loaded nanoparticles exhibited significant antitumor effects and high tumour targeting ability towards HT29 human colon cancer cells. The aforementioned results indicated that the drug loaded nanoparticle prepared in the study had a specific interaction with colon cells. Therefore, the prepared nanoparticle may be used as a potential drug delivery system for the targeted delivery to colon cancers.

Keywords

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2018-19
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri & Aquaculture Journals

Dr. Krish

[email protected]

1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

 
© 2008- 2018 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version